Cell preselection is key to gene therapy success
Berger
Bmj 320(7245): 1296
2000
ISSN/ISBN: 0959-8138 PMID: 10807617 Document Number: 518093
Document emailed within 1 workday
Related Documents
Bubeník, J.; Zeuthen, J.; Bubeníková, D.; Símová, J.; Jandlová, T. 1993: Gene therapy of cancer: use of IL-2 gene transfer and kinetics of local T and NK cell subsets Anticancer Research 13(5a): 1457-1460Messou, Eène.; Gabillard, D.; Moh, R.; Inwoley, Aé.; Sorho, S.; Eholié, S.; Rouet, Fçois.; Seyler, C.; Danel, C.; Anglaret, X. 2008: Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults Bulletin of the World Health Organization 86(6): 435-442
Fedak, P.W.; Verma, S.; Weisel, R.D.; Mickle, D.A.; Li, R.K. 2001: Angiogenesis: protein, gene, or cell therapy? Heart Surgery Forum 4(4): 301-304
Calne, R.Y.; Ghoneim, M.A.; Lee, K.O.; Uin, G.S. 2013: Gene and stem cell therapy for diabetes Clinical Transplants 2013: 111-112
Tong, X.W.; Engehausen, D.G.; Kaufman, R.H.; Agoulnik, I.; Contant, C.; Freund, C.T.; Oehler, M.K.; Kim, T.E.; Hasenburg, A.; Woo, S.L.; Kieback, D.G. 1998: Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy Anticancer Research 18(2a): 713-718
Liu, S.; Lin, Y.; Tang, S.; Yang, H.; Liang, C. 2001: IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma Hua Xi Kou Qiang Yi Xue Za Zhi 19(3): 191-193
Hughes, J.V.; Messner, K.; Burnham, M.; Patel, D.; White, E.M. 1996: Validation of retroviral detection for rodent cell-derived products and gene therapy applications Developments in Biological Standardization 88: 297-304
Wang, H.; Baker, V.V. 2000: Synergistic efficacy of adenovirus-mediated bcl-Xs gene therapy and cisplatin in ovarian cancer cell Zhonghua Fu Chan Ke Za Zhi 35(2): 94-97
Burdach, S.; Nürnberger, W.; Laws, H.J.; Engel, B.C.; Dirksen, U.; Krauth, K.; Pape, H.; Kahn, T.; Körholz, D.; Gadner, H.; Göbel, U.; Jürgens, H. 1996: Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors Bone Marrow Transplantation 18(Suppl 1): S67-S68
Tanaka, M.; Inase, N.; Miyake, S.; Yoshizawa, Y. 2001: Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma Anticancer Research 21(1a): 291-294
Duan, M.L.; Ulfendahl, M.; Ahlberg, A.; Pyykkö, I.; Borg, E. 2000: Future cure of hearing disorders? Gene therapy and stem cell implantation are possible new therapeutic alternatives Lakartidningen 97(10): 1106-1108; 1111-1112
Schwartz-Porsche, D. 1992: Insufficient success in the treatment of epilepsy--mistakes in therapy or resistance to therapy? Deutsche Tierärztliche Wochenschrift 99(10): 407-410
Kim, S.O.; Park, J.G.; Lee, Y.I. 1996: Increased expression of the insulin-like growth factor i (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-i receptor gene activation by hepatitis B virus X gene product Cancer Research 56(16): 3831-3836
Neve, R.L.; Geller, A.I. 1995: A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy Clinical Neuroscience 3(5): 262-267
Parker, L.P.; Wolf, J.K.; Price, J.E. 2000: Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines Annals of Clinical and Laboratory Science 30(4): 395-405
Zhou, L.; Feng, Y.-j.; Zhu, M.-w.; Zhang, W.; Jin, H.-m. 2005: Gene transfer of tumor necrosis factor related apoptosis inducing ligand to endothelial progenitor cell for ovarian cancer therapy Zhonghua Fu Chan Ke Za Zhi 40(12): 822-825
Kutter, D.; Braun, C.; Gallego, F.; Stirn-Thoma, S. 1988: Screening urine before microscopy, by automated test-strip preselection: clinical evaluation of the improved Rapimat II/T (Behring) Clinical Chemistry 34(8): 1600-1602
Commes, T.; Clofent, G.; Ghanem, N.; Zhang, X.G.; Lefranc, M.P.; Bataille, R.; Klein, B. 1993: Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines Leukemia 7(4): 609-617
Zhuang, L.; Guo, H.; Xin, D.; Zhang, Z.; Li, H.; Yuan, X.; Tang, D.; Ding, Y.; Liu, L.; Guo, Y. 2000: Different Wnt-5A gene expressions in the renal cell carcinoma GRC-1 cell line during the cell cycle Chinese Medical Journal 113(4): 306-309
Larsen, C.J. 1994: The BCL2 gene, prototype of a gene family that controls programmed cell death (apoptosis) Annales de Genetique 37(3): 121-134